Literature DB >> 19606496

EYA4, deleted in a case with middle interhemispheric variant of holoprosencephaly, interacts with SIX3 both physically and functionally.

Yuichi Abe1, Akira Oka, Masashi Mizuguchi, Takashi Igarashi, Shumpei Ishikawa, Hiroyuki Aburatani, Shigetoshi Yokoyama, Hiroshi Asahara, Kazuaki Nagao, Masao Yamada, Toshiyuki Miyashita.   

Abstract

Holoprosencephaly (HPE) is the most common congenital malformation of the developing human forebrain, in which the two cerebral hemispheres fail to separate to various degrees. Although pathological mutations have been identified in up to nine genes, a number of other genes as well as environmental factors are likely to be involved in HPE. Here, we describe a case with the middle interhemispheric variant, a milder variant of HPE, carrying a deletion of approximately 10.4 Mb at 6q22.31-q23.2, which includes the EYA4 gene. EYA4 is one of four vertebrate orthologs of the Drosophila melanogaster gene, eyes absent. EYA4 was co-immunoprecipitated with SIX3, the product of one of the known HPE genes. Moreover, the EYA4 protein was observed to be recruited to the nucleus by the nuclear protein SIX3 under a confocal microscope. EYA4 is a transcriptional coactivator, and was shown to cooperate with transcription factor SIX3 by reporter gene assays. These results demonstrate physical and functional association between EYA4 and SIX3, suggesting that EYA4 is a novel candidate gene of HPE, whose haploinsufficiency leads to HPE through the compromised function of SIX3.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19606496     DOI: 10.1002/humu.21094

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  12 in total

Review 1.  The EYA-SO/SIX complex in development and disease.

Authors:  Pin-Xian Xu
Journal:  Pediatr Nephrol       Date:  2012-07-19       Impact factor: 3.714

2.  Clinical findings in patients with GLI2 mutations--phenotypic variability.

Authors:  C D P Bertolacini; L A Ribeiro-Bicudo; A Petrin; A Richieri-Costa; J C Murray
Journal:  Clin Genet       Date:  2011-01-19       Impact factor: 4.438

3.  Developmental expression patterns of candidate cofactors for vertebrate six family transcription factors.

Authors:  Karen M Neilson; Francesca Pignoni; Bo Yan; Sally A Moody
Journal:  Dev Dyn       Date:  2010-12       Impact factor: 3.780

4.  Middle Interhemispheric Variant of Holoprosencephaly - Presenting as Non-Visualized Cavum Septum Pellucidum and An Interhemispheric Cyst in A 19-Weeks Fetus.

Authors:  Akhila Vasudeva; Shalini S Nayak; Rajagopal Kadavigere; Katta M Girisha; Jyothi Shetty
Journal:  J Clin Diagn Res       Date:  2015-09-01

5.  Novel FGF8 mutations associated with recessive holoprosencephaly, craniofacial defects, and hypothalamo-pituitary dysfunction.

Authors:  Mark J McCabe; Carles Gaston-Massuet; Vaitsa Tziaferi; Louise C Gregory; Kyriaki S Alatzoglou; Massimo Signore; Eduardo Puelles; Dianne Gerrelli; I Sadaf Farooqi; Jamal Raza; Joanna Walker; Scott I Kavanaugh; Pei-San Tsai; Nelly Pitteloud; Juan-Pedro Martinez-Barbera; Mehul T Dattani
Journal:  J Clin Endocrinol Metab       Date:  2011-08-10       Impact factor: 5.958

6.  The long noncoding RNA Six3OS acts in trans to regulate retinal development by modulating Six3 activity.

Authors:  Nicole A Rapicavoli; Erin M Poth; Heng Zhu; Seth Blackshaw
Journal:  Neural Dev       Date:  2011-09-21       Impact factor: 3.842

7.  Evaluation of the contribution of the EYA4 and GRHL2 genes in Korean patients with autosomal dominant non-syndromic hearing loss.

Authors:  Ye-Ri Kim; Min-A Kim; Borum Sagong; Seung-Hyun Bae; Hyo-Jeong Lee; Hyung-Jong Kim; Jae Young Choi; Kyu-Yup Lee; Un-Kyung Kim
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

8.  Prevalence and clinical features of hearing loss caused by EYA4 variants.

Authors:  Jun Shinagawa; Hideaki Moteki; Shin-Ya Nishio; Kenji Ohyama; Koshi Otsuki; Satoshi Iwasaki; Shin Masuda; Chie Oshikawa; Yumi Ohta; Yasuhiro Arai; Masahiro Takahashi; Naoko Sakuma; Satoko Abe; Yuika Sakurai; Hirofumi Sakaguchi; Takashi Ishino; Natsumi Uehara; Shin-Ichi Usami
Journal:  Sci Rep       Date:  2020-02-27       Impact factor: 4.379

9.  RNAi phenotypes are influenced by the genetic background of the injected strain.

Authors:  Peter Kitzmann; Jonas Schwirz; Christian Schmitt-Engel; Gregor Bucher
Journal:  BMC Genomics       Date:  2013-01-16       Impact factor: 3.969

10.  Variations in PROKR2, but not PROK2, are associated with hypopituitarism and septo-optic dysplasia.

Authors:  Mark J McCabe; Carles Gaston-Massuet; Louise C Gregory; Kyriaki S Alatzoglou; Vaitsa Tziaferi; Oualid Sbai; Philippe Rondard; Koh-hei Masumoto; Mamoru Nagano; Yasufumi Shigeyoshi; Marija Pfeifer; Tony Hulse; Charles R Buchanan; Nelly Pitteloud; Juan-Pedro Martinez-Barbera; Mehul T Dattani
Journal:  J Clin Endocrinol Metab       Date:  2013-02-05       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.